fema trailer mdl no. 1873 formaldehyde p - US District Court ...

182. CDC Update “Pulmonary
Hemorrhage/Hemosiderosis among
Infants—Cleveland, Ohio, 1993-1996”
March 10, 2000-49 (09); 180-4
183. Chalyasate, Roongrotwattansairi,
Fooanan, Sumitsawan; “Epistaxis in
Chiang Mai University Hospital”
184. Chang “Contact Dermatitis
1997:37:309”
LWFR-EXP15-000413-
LWFR-EXP15-000421
LWFR-EXP15-000422-
LWFR-EXP15-000427
LWFR-EXP15-000428-
LWFR-EXP15-000431
185. Clement PA, Stoot AP, Kaufman L; the
“Influence of formaldehyde on the nasal
mucosa”
186. Clinical and Pathogenic Microbiology
(Second Edition)
187. Pierre Auger, MD, Pierre Gourdeau,
MD, and J. David Miller, PhD “Clinical
Experience with Patients Suffering from
a Chronic Fatigue-Like Syndrome and
Repeated Upper Respiratory Infections
in Relation to Airborne Molds”
188. Torkel Fischer, Klaus Anderson, Ulla
Bengtsson, Peter Frosch, Yen
Gunnarssan, Bo Kreilgard, Torkil
Menne, Stephanie Shaw, Louise
Svennson, John Wilkinson “Clinical
Standardization of the TRUE Test
Formaldehyde Patch”
189. Clinical Toxicology-Stachybotrys
Revisited
190. Douglas H. Linz, MD, MS; Susan M.
Pinney, PhD; James D. Keller, MD, MS;
Michael White, MS; C. Ralph Buncher,
ScD; “Cluster Analysis Applied to
Building-Related Illness”
191. Code of Federal Regulations-29-Part
1910-July 1990
192. Luis M. de la Maza, M.D., Ph.D., Marie
T. Pezzlo, M.A (AAM); Ellen Jo Baron.,
F (AAM) “Color Atlas of Diagnostic
Microbiology”
193. Comment, Comment ILL Number:
55546440
16
LWFR-EXP15-000432-
LWFR-EXP15-000438
LWFR-EXP15-000439-
LWFR-EXP15-000440
LWFR-EXP15-000441-
LWFR-EXP15-000442
LWFR-EXP15-000443-
LWFR-EXP15-000449
LWFR-EXP15-000450-
LWFR-EXP15-000452
LWFR-EXP15-000453-
LWFR-EXP15-000459
LWFR-EXP15-000460-
LWFR-EXP15-000461
LWFR-EXP15-000462-
LWFR-EXP15-000463
LWFR-EXP15-000464-
LWFR-EXP15-000466
194. P. Sherwood Burge, A.S Robertson, and LWFR-EXP15-000467-